Overview

A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This is a study designed to demonstrate the Bioequivalence between Lacosamide (LCM) Tablet and Dry Syrup in Healthy Male Japanese Subjects
Phase:
Phase 1
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
Treatments:
Lacosamide